List of Tables
Table 1. Global OTC Pain Medicines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Acetaminophen
Table 3. Key Players of Ibuprofen
Table 4. Key Players of Aspirin
Table 5. Key Players of Naproxen
Table 6. Key Players of Others
Table 7. Global OTC Pain Medicines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global OTC Pain Medicines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global OTC Pain Medicines Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global OTC Pain Medicines Market Share by Region (2020-2025)
Table 11. Global OTC Pain Medicines Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global OTC Pain Medicines Market Share by Region (2026-2031)
Table 13. OTC Pain Medicines Market Trends
Table 14. OTC Pain Medicines Market Drivers
Table 15. OTC Pain Medicines Market Challenges
Table 16. OTC Pain Medicines Market Restraints
Table 17. Global OTC Pain Medicines Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global OTC Pain Medicines Market Share by Players (2020-2025)
Table 19. Global Top OTC Pain Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Pain Medicines as of 2024)
Table 20. Ranking of Global Top OTC Pain Medicines Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by OTC Pain Medicines Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of OTC Pain Medicines, Headquarters and Area Served
Table 23. Global Key Players of OTC Pain Medicines, Product and Application
Table 24. Global Key Players of OTC Pain Medicines, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global OTC Pain Medicines Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global OTC Pain Medicines Revenue Market Share by Type (2020-2025)
Table 28. Global OTC Pain Medicines Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global OTC Pain Medicines Revenue Market Share by Type (2026-2031)
Table 30. Global OTC Pain Medicines Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global OTC Pain Medicines Revenue Market Share by Application (2020-2025)
Table 32. Global OTC Pain Medicines Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global OTC Pain Medicines Revenue Market Share by Application (2026-2031)
Table 34. North America OTC Pain Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America OTC Pain Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America OTC Pain Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe OTC Pain Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe OTC Pain Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe OTC Pain Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific OTC Pain Medicines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific OTC Pain Medicines Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific OTC Pain Medicines Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America OTC Pain Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America OTC Pain Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America OTC Pain Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa OTC Pain Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa OTC Pain Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa OTC Pain Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 49. GlaxoSmithKline Company Details
Table 50. GlaxoSmithKline Business Overview
Table 51. GlaxoSmithKline OTC Pain Medicines Product
Table 52. GlaxoSmithKline Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 53. GlaxoSmithKline Recent Development
Table 54. Pfizer Company Details
Table 55. Pfizer Business Overview
Table 56. Pfizer OTC Pain Medicines Product
Table 57. Pfizer Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis OTC Pain Medicines Product
Table 62. Novartis Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Sanofi Company Details
Table 65. Sanofi Business Overview
Table 66. Sanofi OTC Pain Medicines Product
Table 67. Sanofi Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. Bayer Company Details
Table 70. Bayer Business Overview
Table 71. Bayer OTC Pain Medicines Product
Table 72. Bayer Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 73. Bayer Recent Development
Table 74. Mallinckrodt Company Details
Table 75. Mallinckrodt Business Overview
Table 76. Mallinckrodt OTC Pain Medicines Product
Table 77. Mallinckrodt Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 78. Mallinckrodt Recent Development
Table 79. Anqiu Lu'an Company Details
Table 80. Anqiu Lu'an Business Overview
Table 81. Anqiu Lu'an OTC Pain Medicines Product
Table 82. Anqiu Lu'an Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 83. Anqiu Lu'an Recent Development
Table 84. Granules India Company Details
Table 85. Granules India Business Overview
Table 86. Granules India OTC Pain Medicines Product
Table 87. Granules India Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 88. Granules India Recent Development
Table 89. Farmson Company Details
Table 90. Farmson Business Overview
Table 91. Farmson OTC Pain Medicines Product
Table 92. Farmson Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 93. Farmson Recent Development
Table 94. Hebei Jiheng Company Details
Table 95. Hebei Jiheng Business Overview
Table 96. Hebei Jiheng OTC Pain Medicines Product
Table 97. Hebei Jiheng Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 98. Hebei Jiheng Recent Development
Table 99. Zhejiang Kangle Company Details
Table 100. Zhejiang Kangle Business Overview
Table 101. Zhejiang Kangle OTC Pain Medicines Product
Table 102. Zhejiang Kangle Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 103. Zhejiang Kangle Recent Development
Table 104. Sri Krishna Pharma Company Details
Table 105. Sri Krishna Pharma Business Overview
Table 106. Sri Krishna Pharma OTC Pain Medicines Product
Table 107. Sri Krishna Pharma Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 108. Sri Krishna Pharma Recent Development
Table 109. Anhui BBCA Likang Company Details
Table 110. Anhui BBCA Likang Business Overview
Table 111. Anhui BBCA Likang OTC Pain Medicines Product
Table 112. Anhui BBCA Likang Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 113. Anhui BBCA Likang Recent Development
Table 114. Seqens Company Details
Table 115. Seqens Business Overview
Table 116. Seqens OTC Pain Medicines Product
Table 117. Seqens Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 118. Seqens Recent Development
Table 119. Xinhua Pharmaceutical Company Details
Table 120. Xinhua Pharmaceutical Business Overview
Table 121. Xinhua Pharmaceutical OTC Pain Medicines Product
Table 122. Xinhua Pharmaceutical Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 123. Xinhua Pharmaceutical Recent Development
Table 124. IOLCP Company Details
Table 125. IOLCP Business Overview
Table 126. IOLCP OTC Pain Medicines Product
Table 127. IOLCP Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 128. IOLCP Recent Development
Table 129. Granules Biocause Company Details
Table 130. Granules Biocause Business Overview
Table 131. Granules Biocause OTC Pain Medicines Product
Table 132. Granules Biocause Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 133. Granules Biocause Recent Development
Table 134. Strides Shasun Company Details
Table 135. Strides Shasun Business Overview
Table 136. Strides Shasun OTC Pain Medicines Product
Table 137. Strides Shasun Revenue in OTC Pain Medicines Business (2020-2025) & (US$ Million)
Table 138. Strides Shasun Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. Authors List of This Report
List of Figures
Figure 1. OTC Pain Medicines Picture
Figure 2. Global OTC Pain Medicines Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global OTC Pain Medicines Market Share by Type: 2024 VS 2031
Figure 4. Acetaminophen Features
Figure 5. Ibuprofen Features
Figure 6. Aspirin Features
Figure 7. Naproxen Features
Figure 8. Others Features
Figure 9. Global OTC Pain Medicines Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global OTC Pain Medicines Market Share by Application: 2024 VS 2031
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Drug Stores Case Studies
Figure 13. E-Commerce Case Studies
Figure 14. OTC Pain Medicines Report Years Considered
Figure 15. Global OTC Pain Medicines Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global OTC Pain Medicines Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global OTC Pain Medicines Market Share by Region: 2024 VS 2031
Figure 18. Global OTC Pain Medicines Market Share by Players in 2024
Figure 19. Global Top OTC Pain Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Pain Medicines as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by OTC Pain Medicines Revenue in 2024
Figure 21. North America OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America OTC Pain Medicines Market Share by Country (2020-2031)
Figure 23. United States OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe OTC Pain Medicines Market Share by Country (2020-2031)
Figure 27. Germany OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific OTC Pain Medicines Market Share by Region (2020-2031)
Figure 35. China OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America OTC Pain Medicines Market Share by Country (2020-2031)
Figure 43. Mexico OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa OTC Pain Medicines Market Share by Country (2020-2031)
Figure 47. Turkey OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE OTC Pain Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. GlaxoSmithKline Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 53. Sanofi Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 54. Bayer Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 55. Mallinckrodt Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 56. Anqiu Lu'an Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 57. Granules India Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 58. Farmson Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 59. Hebei Jiheng Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 60. Zhejiang Kangle Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 61. Sri Krishna Pharma Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 62. Anhui BBCA Likang Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 63. Seqens Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 64. Xinhua Pharmaceutical Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 65. IOLCP Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 66. Granules Biocause Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 67. Strides Shasun Revenue Growth Rate in OTC Pain Medicines Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed